Biotechnology - Epizyme

Filter

Current filters:

Epizyme

Popular Filters

Epizyme shares soar as Celgene deal triggers $25 million milestone payment

Epizyme shares soar as Celgene deal triggers $25 million milestone payment

08-01-2014

US biotech company Epizyme has announced the achievement of the proof of concept milestone in the EPZ-5676…

BiotechnologyCelgeneEpizymeFinancialOncologyResearchUSA

Epizyme's leukemia compound granted orphan drug designation

19-08-2013

US biotech company Epizyme (NASDAQ: EPZM) has been granted orphan drug designation for its experimental…

BiotechnologyCelgeneEpizymeNorth AmericaOncologyRegulation

Epizyme earns upfront $90 million in deal with Celgene; latter posts 17% sales hike

27-04-2012

Privately-held Epizyme and Celgene International Sarl, a subsidiary of USA-based Celgene Corp (Nasdaq:…

BiotechnologyCelgeneEpizymeFinancialLicensingOncologyPharmaceutical

Epizyme earns $4 million pre-clinical milestone from GSK under novel HMT therapeutics alliance

17-10-2011

Privately-held US biotech startup Epizyme says it has achieved a pre-clinical milestones in its alliance…

BiotechnologyEpizymeFinancialGlaxoSmithKlineLicensingOncologyPharmaceutical

Back to top